Literature DB >> 17699335

Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.

Glenn M Chertow1, Paul M Palevsky, Thomas Greene.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17699335     DOI: 10.2215/CJN.01200406

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  Acute kidney injury: Steroids for prevention of AKI after cardiopulmonary bypass.

Authors:  Chirag R Parikh; Jennifer A Schaub
Journal:  Nat Rev Nephrol       Date:  2015-06-30       Impact factor: 28.314

2.  Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.

Authors:  Mark D Okusa; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

3.  What endpoints should not be used for clinical studies of acute kidney injury?

Authors:  Paul M Palevsky; Kathleen D Liu
Journal:  Intensive Care Med       Date:  2017-05-20       Impact factor: 17.440

Review 4.  Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.

Authors:  Sagar U Nigwekar; Sankar D Navaneethan; Chirag R Parikh; John K Hix
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 8.237

Review 5.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

6.  Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.

Authors:  Antonio Jose Inda-Filho; Adriano Caixeta; Marcia Manggini; Nestor Schor
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.